by Mayo Clinic News Network Credit: CC0 Public Domain Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood cells this leukemia affects. "Chronic" m...
Mauro MJ,,Maziarz RT.Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used?.. Mayo Clinic Proceedings . 2006Mauro M J,Maziarz RT.Stem cell transplantation in patients with chronic myelogenous leukemia:when should it be used?. Mayo Clinic Proceedings . ...
Reilly distinguishes “true CNL” from potential mimickers such as “neutrophilic-chronic myeloid leukemia”, or N-CML, “plasma cell dyscrasia-associated neutrophilia”, and “myelodysplastic
Reilly distinguishes “true CNL” from potential mimickers such as “neutrophilic-chronic myeloid leukemia”, or N-CML, “plasma cell dyscrasia-associated neutrophilia”, and “myelodysplastic
Treatment responses to imatinib vary among patients with chronic myeloid leukemia (CML), and definitions of treatment failure and suboptimal response have ... Elias Jabbour, Jorge E Cortes, Hagop M Kantarjian - 《Mayo Clinic Proceedings》 被引量: 192发表: 2009年 Chronic myelogenous leukaemia. In...
Phase II study of pevonedistat (P) + azacitidine (A) versus A in patients (pts) with higher-risk myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemia (CMML), or low-blast acute myelogenous leukemia (LB AML) (NCT02610777). J Clin Oncol. 2020;38:7506. Article Google Scholar ...
It focuses on chronic myeloproliferative disorders (CMPD). It describes the clinical features and symptoms of chronic myelogenous leukemia (CML), pathophysiology, and laborato... K Finnegan - 《Hematology in Practice》 被引量: 3发表: 2007年 加载更多...
Markiewicz T, Osowski S, Marianska B, Moszczynski L (2005) “Automatic recognition of the blood cells of myelogenous leukemia using svm,”In: Proceedings. 2005 IEEE International Joint Conference on Neural Networks, 2005., vol. 4, pp. 2496–2501, IEEE ...
Multivariate risk classifications for chronic (stable)-phase Ph(1+) chronic myelogenous leukemia (CML) are generally focused on hematologic variables, and ... HM Kvasnicka,J Thiele,A Schmitt-Graeff,... - 《Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology》...
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010; 207: 339–344. 13 Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA et al. The common feature of leukemia-associated IDH1 ...